Wolverine Asset Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,352
Closed -$235K 2183
2022
Q4
$235K Sell
23,352
-14,723
-39% -$146K ﹤0.01% 1120
2022
Q3
$373K Buy
38,075
+833
+2% +$8.18K ﹤0.01% 1113
2022
Q2
$364K Buy
37,242
+165
+0.4% +$1.61K ﹤0.01% 1065
2022
Q1
$361K Buy
+37,077
New +$360K ﹤0.01% 1054

Other funds holding AONC

Wolverine Asset Management's AONC Position: Q1 2023 in Review

Wolverine Asset Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 23,352 shares — an estimated $235K sold.

Wolverine Asset Management first reported a position in AONC in Q1 2022 and held it in 4 quarters. The position peaked at $373K in Q3 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Wolverine Asset Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 23,352 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $235K.
  • Wolverine Asset Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q1 2022 and held it in 4 quarters.
  • Wolverine Asset Management's American Oncology Network, Inc. Class A Common Stock position peaked at $373K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.